Immunohistochemical (IHC) tests revealed 100 and 90 percent of the tumor cells to be CDX2 and CK20 positive, respectively, while a moderately high level of tumor cells showed CK7 positivity (Figure 4). The gene discussed is CDX2; the disease is neoplasm.